What DALIA CARE does

Dalia Care is a French digital health company (SAS) founded in 2023 and headquartered in Paris, developing CE-marked software as a medical device (SaMD) for remote monitoring of adults with depressive disorders. The company serves healthcare professionals in France — primarily psychiatrists, general practitioners, and advanced practice nurses — who prescribe the platform to adult patients as part of depression management workflows. The company is registered with a share capital of €13,000 and operates with a headcount of 1–10 employees.

The company's offering comprises two CE-marked products under EU Medical Device Regulation 2017/745: Dalia Monitoring (Class IIa) and Dalia Flow (Class I). The underlying technology is a digital phenotyping platform that ingests continuous physiological data from the Garmin VivoSmart 5 wearable — heart rate, heart rate variability, sleep, and activity — alongside patient responses to validated clinical questionnaires (PHQ-9, ASEC-21, Girerd, and EPDS). A proprietary AI algorithm in the Dalia MD Engine generates daily mental health scores on a 0–27 PHQ-9-equivalent scale, with the company disclosing a mean absolute error of 2–3 points and a 90% confidence interval of ±5 points. The platform architecture is organized into four components: the MD Engine, an HCP Console, a Patient App, and a Health Data Access layer. A product configuration called Dalia Bloom extends the platform to postpartum depression via the EPDS questionnaire.

Dalia Care operates a B2B2C subscription model in which French healthcare providers subscribe to the platform and prescribe it to patients; pricing is not publicly disclosed. Data is hosted on AWS infrastructure within the European Union under HDS certification with GDPR compliance, and prescribing healthcare providers must complete mandatory training before using the device. No funding rounds, revenue figures, or named paying customers have been disclosed.

Name

DALIA CARE

Legal name

Dalia Care

Website

https://daliacare.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

Dalia Care is a French digital health company that develops CE-marked software (Dalia Monitoring, Dalia Flow, Dalia Bloom) using Garmin wearable data and validated questionnaires to remotely monitor depressive disorders for French healthcare providers and their patients.

Ownership category

akta.pro rank

Product category

Digital Health Mental Health Software

NAICS

Social Assistance (624)

SIC

Services-Prepackaged Software (7372), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

SaMD – Monitoring, Triage & Risk Stratification Software (HLACANAE)

akta.pro secondary industries

Behavioral Health & Substance Use Remote Monitoring (HLACAFAD), Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD), Women’s Health & Fertility Therapeutics (Digital) (HLACANAK)

Keywords

• Remote patient monitoring
• Mental health software
• Digital therapeutics platform
• Depression monitoring
• Clinical decision support

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations

Revenue model

1. Telemonitoring Services: Dalia Care operates as a remote patient monitoring (télésurveillance) platform for healthcare providers treating patients with depressive disorders. Revenue is derived from healthcare provider subscriptions for access to the monitoring platform and associated services.

Go-to-market motion1 record

Distribution channels2 records

Core offering

DALIA CARE develops and markets Software as a Medical Device (SaMD) products for the remote monitoring of patients with depressive disorders. Its flagship Class IIa CE-marked solution (Dalia Monitoring) uses digital phenotyping and AI to generate mental-health scores from wearable sensor data and validated clinical questionnaires, and is sold to healthcare professionals who prescribe it to their adult patient cohorts.

Product overview

DALIA CARE offers two distinct CE-marked medical device software (SaMD) products for mental health care. Dalia Monitoring (Class IIa) is a remote patient monitoring system for adult patients with depressive disorders, featuring an AI-driven algorithm that generates daily mental health predictions from wearable physiological data and validated questionnaires. Dalia Flow (Class I) is an appointment planning assistance tool for the same patient population. Both products share a common four-component architecture: a medical-purpose engine module (Dalia MD Engine / Dalia Flow Engine), a web-based HCP Console for healthcare professionals, a mobile patient application, and the Dalia Health Data Access data platform. Dalia Flow additionally offers a Bloom configuration targeting postpartum depression risk. Connected wearable devices (e.g., Garmin VivoSmart 5) are validated optional accessories for physiological data collection.

Differentiator

Problem solved

Functional benefit

Brands

• Dalia Monitoring: Class IIa CE-marked medical device for remote monitoring of patients with depressive disorders. Generates mental health scores and alerts for healthcare professionals based on connected device data and clinical questionnaires.
• Dalia Flow
• Dalia Bloom
• Dalia MD Engine
• Dalia HCP Console
• Dalia Patient App
• Dalia Health Data Access

Products and services

• Dalia Monitoring

Quantifiable outcome

• AI algorithm achieves mean absolute error of 2-3 points on PHQ-9 scale with 90% confidence interval of ±5 points
• +1 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability3 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core and supporting.

• AWS (Amazon Web Services)coreTechnology or IntegrationAWS provides cloud infrastructure hosting for Dalia Care's platform. AWS is certified as HDS (Hébergeur Données de Santé - Health Data Host) compliant with French healthcare data regulations. Data is hosted on HDS-certified servers located in the European Union. Under the EU-US Data Privacy Framework effective July 10, 2023.
• GarmincoreTechnology or IntegrationGarmin VivoSmart 5 is the validated compatible wearable device used with Dalia Monitoring and Dalia Flow. Consumer-grade fitness tracker collects physiological data including sleep, activity, and heart rate. Not classified as a medical device under MDR 2017/745.
• PHQ-9 (Kroenke, Spitzer, Williams)coreOthersPHQ-9 (Patient Health Questionnaire-9) is a validated 9-item depression severity measure used in Dalia Monitoring and Flow Configuration Flow. Freely reproducible clinical instrument.
• ASEC-21 (Antidepressant Side-Effect Checklist)supportingOthers21-item questionnaire evaluating presence and severity of antidepressant side effects used in Dalia Flow and Monitoring Configuration Flow.
• EPDS (Edinburgh Postnatal Depression Scale)coreOthersEPDS is used in Dalia Flow Configuration Bloom for postpartum depression screening. Validated 10-item scale with particular attention to item 10 (self-harm ideas). Used in compliance with conditions defined by authors and Royal College of Psychiatrists.
• Questionnaire de GirerdsupportingOthersTreatment adherence questionnaire used in Dalia Flow and Monitoring. Originally developed for antihypertensive medication adherence. Usage authorized by Pr. Girerd and Alliance HTA France consortium.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Emerging players

• Marigold Health: US peer-support and patient-monitoring platform for mental health that combines peer specialist engagement with symptom tracking for depression and substance use, overlapping with Dalia's HCP-driven remote monitoring model.
• Mindstrong Health: Earlier-stage company focused on digital phenotyping and smartphone-based biomarkers for serious mental illness including depression, overlapping in technology stack with Dalia's wearable-plus-questionnaire approach.

Direct peers

• Akili Interactive: Public digital therapeutics company that has received FDA authorization for software-based treatment of ADHD and is expanding into depression, serving as a direct comparator in SaMD commercialization for mental health.
• NeuroFlow: US behavioral health platform that combines patient-reported outcomes with passive data collection to support measurement-based care in depression and anxiety, with HCP-facing dashboards analogous to Dalia's HCP Console.
• Valera Health: US-based telepsychiatry and mental health platform that combines virtual therapy with patient engagement and symptom monitoring for depression, sharing Dalia's HCP-to-patient telemonitoring model.
• Limbic: UK digital mental health company offering AI-supported self-referral and therapy platforms with measurement-based care for depression and anxiety; complementary European competitor operating in the same SaMD-adjacent regulatory environment.
• Monsenso: Danish mHealth platform that provides remote mental health monitoring using smartphone sensor data and validated questionnaires for depression, bipolar, and other disorders; very similar SaMD-adjacent approach with European footprint.
• Click Therapeutics: Prescription digital therapeutics company developing SaMD for depression and other indications, pursuing FDA clearance and commercialization through healthcare providers—same regulatory and reimbursement pathway as Dalia's Class IIa CE-marked platform.
• Sivan Innovation: Israeli digital-therapeutics company using smartphone-based digital phenotyping and AI for mental health monitoring, with overlapping passive-data-plus-questionnaire methodology and similar SaMD ambitions in depression and other psychiatric conditions.
• Big Health: Digital therapeutics company delivering CE-marked and FDA-cleared software for insomnia and anxiety/depression, with an enterprise B2B2C distribution model closely analogous to Dalia's psychiatrist/GP channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/daliacare

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DALIA CARE